We recently established c-Abl as a potent suppressor of triple-negative breast cancer (TNBC) progression through its reactivation of a p53:p21 signaling axis coupled to senescence. Moreover, we ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results